Tom Shepherd

Tom Shepherd

Captor Therapeutics

---

Chief Executive Officer & President of the Management Board at Captor Therapeutics S.A., a leading publicly listed (WSE: CTX), European drug discovery company focused on targeted protein degradation with a pipeline of 4 drug candidates in oncology and inflammation. Tom has thirty years’ experience of Biotech senior management in Biotechnology companies in the UK, USA, France, Switzerland, Australia and Poland and led three IPOs. Awarded a PhD in biochemistry from Strathclyde University, Glasgow, and CEP diploma from the London Business School. Tom lives in Wroclaw, Poland with his family.